Updated:
NephroGenex, Inc.
NephroGenex, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001338095, and its reported industry is...
Overview
NephroGenex, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001338095, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2016-03-29, it reported net income of USD -22,864,000; total assets of USD 23,046,000 for the fiscal period ended 2015-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- NephroGenex, Inc.
- Former names in filing history
- NephroGenex Inc (2005-08-30 to 2008-04-09)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Jamison, PA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001338095
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents |
|---|---|---|---|---|
| FY2015USD | -$22.9M | $23.0M | $18.8M | |
| FY2014USD | -$16.8M | $29.2M | $14.0M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research NephroGenex, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.